Filing Details
- Accession Number:
- 0001140361-17-039009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-18 17:03:07
- Reporting Period:
- 2017-10-16
- Accepted Time:
- 2017-10-18 17:03:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581720 | Loxo Oncology Inc. | LOXO | Pharmaceutical Preparations (2834) | 462996673 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612217 | Z. Avi Naider | C/O Loxo Oncology, Inc. 281 Tresser Blvd, 9Th Floor Stamford CT 06901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-10-16 | 5,000 | $90.00 | 144,118 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
